This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
The Agency for Healthcare Research and Quality (AHRQ) has released two new continuing medical education/continuing education (CME/CE) modules based on Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease, a comparative effectiveness review developed by the Agency's Effective Health Care Program. The formats include a supplement to the electronic Journal of Managed Care Pharmacy and a video discussion.
Internet Citation: AHRQ releases new CME/CE activities: Research Activities, September 2011.
September 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/news/newsletters/research-activities/sep11/0911RA36.html
The information on this page is archived and provided for reference purposes only.